2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Speech Disorders: new trials by email Literature Review of Speech Disorders trials Research Report on Speech Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A 24-month Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia AADvac1 40 µg, AADvac1 160 µg - Primary Progressive Nonfluent Aphasia | Phase 1 | Unknown | Axon Neuroscience SE | 33 | 2017-07-31 | 2019-11-14 |
| Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients. Wait first, then levetiracetam, Levetiracetam first, then wait - Aphasia, Stroke | Phase 1 | Unknown | Kessler Foundation | 50 | 2005-09-01 | 2021-02-17 |
Aphasia (1) · Aphasia, Primary Progressive (1) · Pick Disease of the Brain (1) · Primary Progressive Nonfluent Aphasia (1) · Stroke (1) · Tauopathies (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Communication Disorders (2) · Language Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Aphasia (1) · Cardiovascular Diseases (1) · Cerebrovascular Disorders (1) · Dementia (1) · Frontotemporal Dementia (1)
AADvac1 (1) · Levetiracetam (1)
Axon Neuroscience SE (1) · Kessler Foundation (1)
Germany (1) · United States (1)
A.M. Barrett, MD (1) · Markus Otto, Prof (1)
2017 (1)